Targeting CB2 receptors and the endocannabinoid system for the treatment of pain.
about
Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trialsIs lipid signaling through cannabinoid 2 receptors part of a protective system?Minireview: From the bench, toward the clinic: therapeutic opportunities for cannabinoid receptor modulationMechanisms of acupuncture-electroacupuncture on persistent painThe effects of caffeine, nicotine, ethanol, and tetrahydrocannabinol on exercise performanceDiscovery of prostamide F2α and its role in inflammatory pain and dorsal horn nociceptive neuron hyperexcitabilityInvolvement of peripheral cannabinoid and opioid receptors in β-caryophyllene-induced antinociceptionCB2 Cannabinoid Receptor Knockout in Mice Impairs Contextual Long-Term Memory and Enhances Spatial Working Memory.Brain CB₂ Receptors: Implications for Neuropsychiatric Disorders.hCB2 ligand-interaction landscape: cysteine residues critical to biarylpyrazole antagonist binding motif and receptor modulation.In vivo pharmacology of endocannabinoids and their metabolic inhibitors: therapeutic implications in Parkinson's disease and abuse liabilityCannabinoid CB1 receptor facilitation of substance P release in the rat spinal cord, measured as neurokinin 1 receptor internalization.Pain-related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: modulation by cannabinoids.Differential activation of intracellular versus plasmalemmal CB2 cannabinoid receptors.CB2: a cannabinoid receptor with an identity crisisTopical analgesics for neuropathic pain: preclinical exploration, clinical validation, future development.Pharmacological characterization of AM1710, a putative cannabinoid CB2 agonist from the cannabilactone class: antinociception without central nervous system side-effectsCB1 and CB2 receptor agonists promote analgesia through synergy in a murine model of tumor painAnandamide suppresses pain initiation through a peripheral endocannabinoid mechanism.Functional selectivity in CB(2) cannabinoid receptor signaling and regulation: implications for the therapeutic potential of CB(2) ligands.Attenuation of persistent pain-related behavior by fatty acid amide hydrolase (FAAH) inhibitors in a rat model of HIV sensory neuropathy.Activation of cannabinoid CB2 receptors reduces hyperalgesia in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.Antinociceptive effects, acute toxicity and chemical composition of Vitex agnus-castus essential oilThe fatty acid amide hydrolase (FAAH) inhibitor PF-3845 acts in the nervous system to reverse LPS-induced tactile allodynia in mice.Therapeutic modulation of cannabinoid lipid signaling: metabolic profiling of a novel antinociceptive cannabinoid-2 receptor agonistInvestigations on the 4-quinolone-3-carboxylic acid motif part 5: modulation of the physicochemical profile of a set of potent and selective cannabinoid-2 receptor ligands through a bioisosteric approach.Activation of cannabinoid receptor 2 inhibits experimental cystitisModulating the endocannabinoid system in human health and disease--successes and failuresNeuronal expression of CB2 cannabinoid receptor mRNAs in the mouse hippocampus.Neuroprotective effect of endogenous cannabinoids on ischemic brain injury induced by the excess microglia-mediated inflammation.Activation of CB2 receptors as a potential therapeutic target for migraine: evaluation in an animal modelDeciphering the mechanism(s) of action of natural products: analgesic peroxide oil as example.Clinical implications for cannabinoid use in the rheumatic diseases: potential for help or harm?Modulation of neuropathic-pain-related behaviour by the spinal endocannabinoid/endovanilloid system.Simultaneous detection of multiple designer drugs in serum, urine, and CSF in a patient with prolonged psychosis.Endocannabinoids and neuropathic pain: focus on neuron-glia and endocannabinoid-neurotrophin interactions.Turning Over a New Leaf: Cannabinoid and Endocannabinoid Modulation of Immune Function.Mistic and TarCF as fusion protein partners for functional expression of the cannabinoid receptor 2 in Escherichia coli.Current and Future Issues in the Development of Spinal Agents for the Management of Pain.Signaling Mechanism of Cannabinoid Receptor-2 Activation-Induced β-Endorphin Release.
P2860
Q24625489-04D59381-4776-4C9E-BEE8-788C21100F70Q24633122-6D885848-B081-43DE-8193-74FC47917ACFQ26829111-5BA13469-08B2-4C6D-9A01-B19417E7139DQ26866252-C1097B75-A51F-4CED-BA2E-2375F1D26EA4Q28303831-A752227E-D5D5-4649-92FE-01A19E5C18FFQ28480988-963A60EC-207E-4734-B16F-816D553A143FQ29395820-A5532F53-D243-4653-8509-7822BB76B758Q30392902-36B61165-7E85-4072-8817-F06D6E153D94Q33664105-2B521BEC-20DE-4E5A-AEDD-48A13C802375Q33733994-E4E29D8E-23FA-4E42-B221-D2F40D195131Q33751118-1BE883EF-6F1C-4A43-8754-615A552B3068Q33803774-4CBAD2F9-CD70-4743-B01C-E38867C66A3DQ34033859-4020C9A7-ACDD-4BC1-98D0-1FD4906F0149Q34089051-FC1BA869-B58D-4413-A79C-B0594821F80AQ34098185-F9CD6773-3C61-417A-857C-CE4366C33B0FQ34376548-8482309C-D1C7-4E08-A8E0-1D49E329C713Q34946680-BD88E05D-E3A3-4F31-9C7D-8432BE61051BQ35162945-8E639E23-9579-4CE5-B86F-F64C64253DC1Q35678770-CAF26FCA-DE29-46ED-AEA0-1EBC777662E8Q35688511-4DF8B099-CFAD-49C6-A9C4-694E82593D76Q35689152-41BBDFCD-0907-4B14-8CC9-4F81ED8F70C1Q35731427-EEB2B07D-1860-4CD7-9640-8EB5FD7AF87EQ35749897-8EAC95FC-9523-407F-B37D-9AFFA6C871F5Q36176531-EB2E7A82-A6CD-4188-A6A4-93FA06D9C523Q36385052-3660ACB0-4EDA-408A-B522-1DCE52AC7BDBQ36452404-3FC470E5-1BC9-49FF-899F-77153861523DQ36838206-F48F2A10-BFAB-4926-A78B-3ED2B5B34F6DQ36933683-35244393-AB5E-4898-8EBC-4BA12118A241Q37029175-D57C461E-042E-4E5C-AFF4-844CEC27B31DQ37060774-D9A569CF-AB5C-4693-AC9A-D4EB9138EF91Q37716463-591ECCE1-748E-4475-B041-45153729CDB1Q37872360-38EB6650-3413-486F-83EF-38FA5779EB22Q38011117-D1836146-FE96-4114-A652-2142B929618FQ38056397-F8AD94AF-0539-4295-852E-C9DF23A2DCA6Q38060837-C2046E76-2DC8-48C4-BEB1-3329DE408CF4Q38185071-D3C35284-9773-4D6C-831B-97A91FC91870Q38520997-9B05A08D-27A6-478E-A79A-B2EDE3F8E2CEQ38540669-8FF4AD27-7D74-4A1B-B186-6FB0C77EA477Q38727831-7F04491D-AE65-4B26-B12A-2EC813970D37Q38860499-B176A251-5560-4E43-9D63-9A206EE55861
P2860
Targeting CB2 receptors and the endocannabinoid system for the treatment of pain.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeting CB2 receptors and the endocannabinoid system for the treatment of pain.
@en
Targeting CB2 receptors and the endocannabinoid system for the treatment of pain.
@nl
type
label
Targeting CB2 receptors and the endocannabinoid system for the treatment of pain.
@en
Targeting CB2 receptors and the endocannabinoid system for the treatment of pain.
@nl
prefLabel
Targeting CB2 receptors and the endocannabinoid system for the treatment of pain.
@en
Targeting CB2 receptors and the endocannabinoid system for the treatment of pain.
@nl
P2093
P2860
P1476
Targeting CB2 receptors and the endocannabinoid system for the treatment of pain.
@en
P2093
Andrea G Hohmann
Christopher J Fowler
Garth Whiteside
Praveen Anand
P2860
P304
P356
10.1016/J.BRAINRESREV.2008.12.003
P577
2008-12-25T00:00:00Z